Charles Schwab Investment Management Inc Arcutis Biotherapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 859,846 shares of ARQT stock, worth $7.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

859,846

Previous 851,324 1.0%

Holding current value

$7.96 Million

Previous $7.92 Million 1.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$8.32 - $11.0 $70,903 - $93,742	8,522 Added 1.0%	859,846 $8 Million
Q2 2024 Aug 12, 2024	BUY	$7.24 - $12.53 $728,344 - $1.26 Million	100,600 Added 13.4%	851,324 $7.92 Million
Q1 2024 May 08, 2024	BUY	$3.25 - $11.77 $583,069 - $2.11 Million	179,406 Added 31.4%	750,724 $7.44 Million
Q4 2023 Feb 06, 2024	BUY	$1.84 - $4.82 $345,009 - $903,774	187,505 Added 48.85%	571,318 $1.85 Million
Q3 2023 Nov 08, 2023	BUY	$5.31 - $10.98 $286,055 - $591,503	53,871 Added 16.33%	383,813 $2.04 Million
Q2 2023 Aug 09, 2023	BUY	$7.51 - $15.0 $206,074 - $411,600	27,440 Added 9.07%	329,942 $3.14 Million
Q1 2023 May 11, 2023	BUY	$10.23 - $17.14 $7,918 - $13,266	774 Added 0.26%	302,502 $3.33 Million
Q4 2022 Feb 13, 2023	BUY	$13.96 - $20.4 $148,464 - $216,953	10,635 Added 3.65%	301,728 $4.47 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $1.32 Million - $1.99 Million	73,833 Added 33.98%	291,093 $5.56 Million
Q2 2022 Aug 15, 2022	BUY	$16.33 - $22.2 $266,113 - $361,771	16,296 Added 8.11%	217,260 $4.63 Million
Q1 2022 May 13, 2022	BUY	$14.38 - $22.79 $36,108 - $57,225	2,511 Added 1.27%	200,964 $3.87 Million
Q4 2021 Feb 11, 2022	BUY	$14.98 - $25.5 $39,187 - $66,708	2,616 Added 1.34%	198,453 $4.12 Million
Q3 2021 Nov 16, 2021	BUY	$19.28 - $27.1 $47,332 - $66,530	2,455 Added 1.27%	195,837 $4.68 Million
Q2 2021 Aug 16, 2021	BUY	$24.42 - $34.75 $334,602 - $476,144	13,702 Added 7.63%	193,382 $5.28 Million
Q1 2021 May 17, 2021	BUY	$24.47 - $36.98 $935,757 - $1.41 Million	38,241 Added 27.04%	179,680 $5.2 Million
Q4 2020 Feb 16, 2021	BUY	$17.82 - $31.73 $549,141 - $977,791	30,816 Added 27.86%	141,439 $3.98 Million
Q3 2020 Nov 13, 2020	BUY	$23.44 - $32.28 $993,316 - $1.37 Million	42,377 Added 62.09%	110,623 $3.24 Million
Q2 2020 Aug 14, 2020	BUY	$24.48 - $36.56 $1.13 Million - $1.69 Million	46,225 Added 209.91%	68,246 $2.06 Million
Q1 2020 May 15, 2020	BUY	$18.5 - $36.9 $407,388 - $812,574	22,021 New	22,021 $657,000

Others Institutions Holding ARQT

# of Institutions

197

Shares Held

129M

Call Options Held

738K

Put Options Held

82K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $557M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Arcutis Biotherapeutics, Inc. Transaction History